换一批Evaluation of treatment response and resistance in metastatic renal cell cancer (mRCC) using integrated <sup>18</sup>F-Fluorodeoxyglucose (<sup>18</sup>F-FDG) positron emission tomography/magnetic resonance imaging (PET/MRI); The REMAP study.
第一作者：
Christian,Kelly-Morland
第一单位：
Department of Cancer Imaging, King's College London Division of Imaging Sciences & Biomedical Engineering, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. christian.kellymorland@gmail.com.
作者：
医学主题词
成年人(Adult);老年人(Aged);癌, 肾细胞(Carcinoma, Renal Cell);细胞增殖(Cell Proliferation);造影剂(Contrast Media);女(雌)性(Female);氟脱氧葡萄糖F18(Fluorodeoxyglucose F18);人类(Humans);咪唑类(Imidazoles);吲唑类(Indazoles);吲哚类(Indoles);伦敦(London);男(雄)性(Male);中年人(Middle Aged);肿瘤转移(Neoplasm Metastasis);肿瘤, 继发原发性(Neoplasms, Second Primary);正电子发射断层显像术(Positron-Emission Tomography);嘧啶类(Pyrimidines);吡咯类(Pyrroles);磺胺类(Sulfonamides);治疗结果(Treatment Outcome)
DOI
10.1186/s12885-017-3371-9
PMID
28578690
发布时间
2025-05-30
- 浏览101
BMC cancer
392页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
